NKTX (STOCKS)
Nkarta, Inc. Common Stock
$2.300000
-0.090000 (-3.77%)
Prev close: $2.390000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Paul J. Hastings
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $182.73M
- Employees
- 157
- P/E (TTM)
- -1.46
- P/B (TTM)
- 0.69
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.54 | $-0.38 | -0.1565 | -40.81% |
|
Mar 2026 (Q1)
|
$-0.37 | $-0.38 | +0.0100 | +2.63% |
|
Dec 2025 (Q4)
|
$-0.37 | $-0.32 | -0.0456 | -14.06% |
|
Sep 2025 (Q3)
|
$-0.29 | $-0.32 | +0.0296 | +9.26% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $14.93M |
| Operating Expenses | $132.25M |
| Depreciation and Amortization | $9.64M |
| Research and Development | $99.51M |
| Other Operating Expenses | $23.10M |
| Operating Income/Loss | -$132.25M |
| Income/Loss From Continuing Operations After Tax | -$117.32M |
| Income/Loss From Continuing Operations Before Tax | -$117.32M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$117.32M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$117.32M |
| Net Income/Loss Available To Common Stockholders, Basic | -$117.32M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.58 |
| Diluted Earnings Per Share | -$1.58 |
| Basic Average Shares | 148,419,531 |
| Diluted Average Shares | 148,419,531 |
| Assets | $337.65M |
| Current Assets | $188.05M |
| Noncurrent Assets | $149.60M |
| Fixed Assets | $56.77M |
| Other Non-current Assets | $92.83M |
| Liabilities | $89.91M |
| Current Liabilities | $23.56M |
| Accounts Payable | $3.82M |
| Wages | $4.21M |
| Other Current Liabilities | $15.53M |
| Noncurrent Liabilities | $66.35M |
| Equity | $247.74M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $247.74M |
| Liabilities And Equity | $337.65M |
| Net Cash Flow From Operating Activities | -$92.76M |
| Net Cash Flow From Operating Activities, Continuing | -$92.76M |
| Net Cash Flow From Investing Activities | $63.55M |
| Net Cash Flow From Investing Activities, Continuing | $63.55M |
| Net Cash Flow From Financing Activities | $746.00K |
| Net Cash Flow From Financing Activities, Continuing | $746.00K |
| Net Cash Flow | -$28.46M |
| Net Cash Flow, Continuing | -$28.46M |
| Comprehensive Income/Loss | -$117.57M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$118.11M |
| Other Comprehensive Income/Loss | -$62.33M |